LIC MF Healthcare Fund Regular Growth
Medium
Risk
Equity
Other
+
13.21
%
13.21
%
3Y annualised
+
0.06
%
0.06
%
1D
1M
6M
1Y
3Y
All
Fund size
58
NAV:
Mar 7, 2024
23.4603
Sector
Tech
Type
Equity
Launched
Feb 2019
Min Investment
5000
Expense Ratio
2
Risk
Medium
Portfolio allocation
Top 10 Holdings
% Value
Sun Pharmaceuticals Industries Ltd
16.04
%
Zydus Lifesciences Ltd
7.05
%
Dr Reddy's Laboratories Ltd
6.9
%
Cipla Ltd
6.18
%
J.B. Chemicals & Pharmaceuticals Ltd
5.96
%
Piramal Pharma Ltd
5.41
%
Torrent Pharmaceuticals Ltd
5.39
%
Apollo Hospitals Enterprise Ltd
4.97
%
Abbott India Ltd
4.75
%
Divi's Laboratories Ltd
4.72
%
Expense ratio, exit load and tax
Expense Ratio:
2
%
Inclusive of GST
Exit load
Exit load of 1.0% if redeemed within 90.0 Days, 0.0 % if redeemed after 90.0 Days.
Tax implication
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.
Fund house & investment objective
LIC MF Healthcare Fund Regular Growth
More details
Investment objective
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.
Scheme Information Document
Mutual Fund investments are subject to market risks. Read all scheme-related documents carefully. Past performance is not an indicator of future returns.
Calculate returns
One-time
Monthly SIP
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
* Returns are calculated as per lifetime average per annum returns of the fund.
Calculate returns
Monthly SIP
One-time
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
